Filtered By:
Source: Stroke
Management: Health Insurance
Therapy: Hormonal Therapy

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen Clinical Sciences
Conclusions— Both route of estrogen administration and progestogens were important determinants of IS. Our findings suggest that transdermal estrogens might be the safest option for short-term hormone therapy use.
Source: Stroke - June 26, 2016 Category: Neurology Authors: Canonico, M., Carcaillon, L., Plu-Bureau, G., Oger, E., Singh-Manoux, A., Tubert-Bitter, P., Elbaz, A., Scarabin, P.-Y. Tags: Cardiovascular Disease, Epidemiology, Risk Factors, Women Clinical Sciences Source Type: research